Journal of Pharmaceutical Care & Health Systems

Journal of Pharmaceutical Care & Health Systems
Open Access

ISSN: 2376-0419

+44 1300 500008

Editorial - (2020)Volume 7, Issue 2

COVID-19 Infection in Beijing

Khaled Barakat*
 
*Correspondence: Khaled Barakat, Department of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada, Tel: (780) 492-5783, Email:

Author info »

Editorial

Since the first case of a novel coronavirus (COVID-19) infection pneumonia was detected in Wuhan, China, a series of confirmed cases of the COVID-19 were found in Beijing. We analyzed the data of 262 confirmed cases to determine the clinical and epidemiological characteristics of COVID-19 in Beijing.

We collected patients who were moved by Beijing Emergency Medical Service to the assigned clinics. The data on segment, epidemiological, clinical, research center test for the COVID-19 infection, indicative grouping, bunch case and result were acquired. Moreover we looked at the attributes among serious and normal affirmed cases which including gentle cases, no-pneumonia cases and asymptomatic cases, and we likewise analyzed the highlights between COVID-19 and 2003 SARS.

By Feb 10, 2020, 262 patients were moved from the clinics across Beijing to the assigned emergency clinics for extraordinary treatment of the COVID-19 contaminated by Beijing crisis clinical assistance. Among of 262 patients, 46 (17.6%) were serious cases, 216 (82.4%) were normal cases, which including 192 (73.3%) gentle cases, 11(4.2%) non-pneumonia cases and 13 (5.0%) asymptomatic cases individually. The middle period of patients was 47.5 years old and 48.5% were male. 192 (73.3%) patients were inhabitants of Beijing, 50 (26.0%) of which had been to Wuhan, 116 (60.4%) had close contact with affirmed cases, 21 (10.9%) had no contact history. The most widely recognized indications at the beginning of sickness were fever (82.1%), hack (45.8%), exhaustion (26.3%), dyspnea (6.9%) and migraine (6.5%). The middle hatching time frame was 6.7 days, the timespan between ailment beginning and seeing a specialist was 4.5 days. As of Feb 10, 17.2% patients have released and 81.7% patients stay in medical clinic in our examination, the casualty of COVID-19 contamination in Beijing was 0.9%.

Based on this examination, we gave the proportion of the COVID-19 disease on the serious cases to the mellow, asymptomatic and non-pneumonia cases in Beijing. Populace was commonly powerless, and with a generally low casualty rate. The measures to forestall transmission was fruitful at beginning phase, the following stages on the COVID-19 contamination ought to be centered around early confinement of patients and isolate for close contacts in families and networks in Beijing.

Author Info

Khaled Barakat*
 
Department of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada
 

Citation: Barakat K (2020) COVID-19 Infection in Beijing. J Pharma Care Health Sys 7:211. doi: 10.35248/2376-0419.20.7.211.

Received: 07-Jul-2020 Accepted: 17-Jul-2020 Published: 24-Jul-2020 , DOI: 10.35248/2376-0419.20.7.211

Copyright: © 2020 Barakat K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top